CHINA - August 22, 2026 - Deyang Rata Technology Co., Ltd. has introduced the SIRL-6000L, a mobile resistive-inductive ...

Only Slate Plus members can gift Slate stories. Become a member to share 10 free articles a month. Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, ...

Back in 2023, Chris Lattner, creator of LLVM, and his team at Modular unveiled a new language called Mojo. Its syntax resembled Python, but it compiled to machine-native code and offered memory-safety ...

Driving an RV lets you bring the comforts of home along on your road trip, but having a portable generator is essential. It powers your electric appliances and charges electronics, like your phone and ...

I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...